Recent Finacing
Recent Raise
PolarityTE develops SkinTE, a regenerative tissue product under IND, conducting Phase III COVER DFUS II to evaluate 12-week closure of Wagner 1 diabetic foot ulcers; interim Q1 2025.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at PolarityTE.
